Thyrocare Technologies Ltd.

NSE: THYROCARE BSE: 539871 SECTOR: Hospital & Healthcare Services  84k   536   56

421.55
+2.15 (0.51%)
NSE: 29 Mar 4:00 PM

Price Summary

Today's High

₹ 426.25

Today's Low

₹ 416

52 Week High

₹ 916.95

52 Week Low

₹ 415.4

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

2231.27 Cr.

Enterprise Value

2219.27 Cr.

No. of Shares

5.29 Cr.

P/E

33.1

P/B

4.44

Face Value

₹ 10

Div. Yield

3.55 %

Book Value (TTM)

₹  95.04

CASH

12 Cr.

DEBT

0 Cr.

Promoter Holding

71.14 %

EPS (TTM)

₹  12.73

Sales Growth

18.4%

ROE

31.68 %

ROCE

43.42%

Profit Growth

26.95 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Thyrocare Technologies Ltd.

Aarogyam WHATERS

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year18.4%
3 Year14.89%
5 Year13.55%

Profit Growth

1 Year28.43%
3 Year16.83%
5 Year26.62%

ROE%

1 Year31.68%
3 Year26.73%
5 Year24.7%

ROCE %

1 Year43.42%
3 Year36.64%
5 Year35.22%

Debt/Equity

0

Price to Cash Flow

21.11

Interest Cover Ratio

88.1344537815126

CFO/PAT (5 Yr. Avg.)

1.03458702064897

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2022 71.14 100
Sep 2022 71.14 100
Jun 2022 71.18 100
Mar 2022 71.18 100
Dec 2021 71.18 100
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 16.879285146744% for the Past 3 years.
  • Company has been maintaining healthy ROE of 26.732664287634% over the past 3 years.
  • Company has been maintaining healthy ROCE of 36.6389105970984% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 88.1344537815126.
  • The Company has been maintaining an effective average operating margins of 40.1682198389943% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 21.5934913923921 days.
  • Company has a healthy liquidity position with current ratio of 3.8318129042959.
  • The company has a good cash flow management; CFO/PAT stands at 1.03458702064897.

 Limitations

  • The company has shown a poor revenue growth of 14.8896490589861% for the Past 3 years.
  • Promoter pledging has increased from 71.14% to 100% in 1 quarter.
  • Promoter pledging is high as 100%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 110.2 123.33 119.24 125.23 117.17
Total Expenditure 74.2 86.5 85.44 95.69 91.26
Operating Profit 36 36.83 33.8 29.54 25.91
Other Income 1.1 1.7 0.89 1.16 1.27
Interest 0.6 0.58 0.55 0.51 0.59
Depreciation 7.4 8.57 7.58 8.07 9.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 29.1 29.38 26.56 22.12 17.58
Tax 6.5 9.03 6.44 7.82 4.95
Profit After Tax 22.6 20.35 20.12 14.3 12.63
Adjusted EPS (Rs) 4.27 3.85 3.8 2.7 2.39

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 331.79 370.28 401.06 474.27 561.53
Total Expenditure 192.79 222.14 233.29 303.53 330.7
Operating Profit 139 148.14 167.77 170.74 230.83
Other Income 23.63 13.66 9.42 12.28 7.4
Interest 0.4 0.47 1.32 0.66 2.38
Depreciation 12.08 14.47 19.54 21.08 28.47
Exceptional Items -2.19 0 -44.33 0 0
Profit Before Tax 147.96 146.86 112 161.28 207.38
Tax 51.93 51.63 32.68 41.51 55.33
Net Profit 96.2 95.33 79.44 118.36 152.01
Adjusted EPS (Rs.) 17.88 18.04 15.01 22.65 28.74

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 53.72 52.8 52.84 52.87 52.9
Total Reserves 400.16 402.98 325.39 392.59 467.8
Borrowings 0 0 0 0 0
Other N/C liabilities 12.74 5.93 1.77 4.78 0.43
Current liabilities 18.33 24.52 50.75 62.69 60.29
Total Liabilities 484.95 486.23 430.75 512.93 581.42
Assets
Net Block 101.69 108.26 111.56 118.03 148.31
Capital WIP 0 1.28 3.87 8.28 2.15
Intangible WIP 0 0 0 0 0
Investments 214.67 214.67 170.34 170.34 170.34
Loans & Advances 29.34 49.76 27.67 29.06 23.77
Other N/C Assets 1.5 0.25 3.66 4.72 5.83
Current Assets 137.75 112.01 113.65 182.5 231.02
Total Assets 484.95 486.23 430.75 512.93 581.42
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 147.96 146.86 156.33 161.28 207.38
Adjustment 0.38 8.98 15.76 14.16 38.05
Changes in Assets & Liabilities 11.17 2.19 8.49 -20.78 -83.42
Tax Paid -47.99 -61.47 -44.25 -43.59 -56.33
Operating Cash Flow 111.52 96.56 136.33 111.07 105.68
Investing Cash Flow -48.26 -3.3 26.84 -53.09 -12.32
Financing Cash Flow -64.73 -96.14 -162.65 -57.81 -86.91
Net Cash Flow -1.47 -2.88 0.52 0.17 6.45

Corporate Actions

Investors Details

PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Promoters 71.18 71.18 71.18 71.14 71.14
dr velumani a - 27.57 27.57 27.57 27.57
dr. a. velumani - - - - -
dr.a.velumani 28.02 - - - -
thyrocare publicat... 12.36 12.16 12.16 12.16 12.16
thyrocare properti... - 9.71 9.71 9.71 9.71
thyrocare properti... - - - - -
thyrocare properti... 9.88 - - - -
a sundararaju - 4.96 4.96 4.96 4.96
a. sundararaju huf - - - - -
a.sundararaju huf 4.57 - - - -
sumathi infra proj... 2.98 2.93 2.93 2.93 2.93
a. velumani huf - - - - -
a.velumani huf 2.83 - - - -
a velumani - 1.70 1.70 1.70 1.70
mahima advertising... 2.38 2.35 2.35 2.35 2.35
amruta velumani 1.42 1.40 1.40 1.40 1.40
anand velumani 1.20 1.18 1.18 1.18 1.18
a.sundararaju 0.47 - - - -
a. sundararaju - - - - -
pavilion commercia... 0.02 - - - -
pavilion commercia... - - - - -
PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Investors 28.82 28.82 28.82 28.86 28.86
reliance capital t... - - 7.83 7.75 6.79
reliance capital t... - 7.66 - - -
nalanda india equi... - - - - -
arisaig asia consu... 6.11 - - - -
reliance capital t... - - - - -
aditya birla sun l... - - 4.18 4.12 3.65
new horizon opport... - - - 2.00 2.79
birla sun life tru... - 3.98 - - -
nippon life india ... - - - - -
nippon life india ... 3.57 - - - -
sbi magnum midcap ... - 3.45 - - -
sundaram mutual fu... - 1.62 1.62 2.46 -
sundaram mutual fu... - - - - -
dsp blackrock micr... - 2.98 - - -
bakak financial se... 2.84 - - - -
sbi magnum midcap ... - - 2.16 - -
dsp blackrock smal... - - 2.11 2.11 2.11
fundsmith emerging... 1.46 1.20 1.51 1.64 1.64
ai mehwar commerci... - - - 1.48 1.48
al mehwar commerci... - - - - -
abu dhabi investme... - 1.48 1.48 - -
fil investments(ma... - 1.35 1.09 - -
old well emerging ... - - - - -
dsp blackrock emer... - 1.05 - - -
llp 0.13 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Thyrocare Technologies submits analyst meet intimation13 Mar 2023, 4:55PM Thyrocare Technologies informs about disclosure10 Mar 2023, 3:12PM Thyrocare Technologies informs about investors meet 27 Feb 2023, 5:09PM Thyrocare Technologies informs about audio recording of earning call4 Feb 2023, 10:29AM Thyrocare Tech. - Quaterly Results3 Feb 2023, 3:39PM Thyrocare Tech. - Quaterly Results3 Feb 2023, 3:39PM Thyrocare Tech. - Quaterly Results3 Feb 2023, 3:39PM Thyrocare Technologies informs about disclosure of related party transactions25 Nov 2022, 5:14PM Thyrocare Technologies informs about investor presentation16 Nov 2022, 3:38PM Thyrocare Technologies to make investment of Rs 2.55 crore in Pulse Hitech Health Services12 Nov 2022, 2:51PM Thyrocare Tech. - Quaterly Results11 Nov 2022, 5:25PM Thyrocare Tech. - Quaterly Results11 Nov 2022, 5:25PM Thyrocare Tech. - Quaterly Results11 Nov 2022, 5:25PM Thyrocare Technologies informs about conference call 3 Nov 2022, 12:40PM Thyrocare Technologies informs about analyst meet intimation23 Sep 2022, 12:26PM Thyrocare Technologies informs about conference call19 Sep 2022, 4:28PM Thyrocare Technologies informs about allotment of equity shares17 Sep 2022, 1:20PM Thyrocare Technologies informs about disclosure16 Sep 2022, 3:16PM Thyrocare Technologies informs about disclosure16 Sep 2022, 11:58AM Thyrocare Tech. - Quaterly Results1 Aug 2022, 6:32PM Thyrocare Tech. - Quaterly Results1 Aug 2022, 6:32PM Thyrocare Tech. - Quaterly Results1 Aug 2022, 6:32PM Thyrocare Technologies informs about conference call27 Jul 2022, 3:19PM Thyrocare Technologies informs about AGM 13 Jul 2022, 9:55AM Thyrocare Technologies informs about earnings call9 May 2022, 3:50PM Thyrocare Technologies informs about audio recording of conference call7 May 2022, 4:30PM Thyrocare Technologies informs about disclosure5 May 2022, 4:42PM Thyrocare Technologies informs about link for the earnings call5 May 2022, 12:32PM Thyrocare Technologies reports 44% fall in Q4 consolidated net profit30 Apr 2022, 1:03PM Thyrocare Technologies informs about record date30 Apr 2022, 12:05PM Thyrocare Technologies informs about outcome of board meeting30 Apr 2022, 12:02PM Thyrocare Technologies informs about outcome of board meeting30 Apr 2022, 10:41AM Thyrocare Tech. - Quaterly Results29 Apr 2022, 11:24PM Thyrocare Tech. - Quaterly Results29 Apr 2022, 11:24PM Thyrocare Technologies informs about newspaper publication15 Feb 2022, 4:53PM Thyrocare Tech. - Quaterly Results12 Feb 2022, 7:49PM Thyrocare Tech. - Quaterly Results12 Feb 2022, 7:49PM Thyrocare Technologies informs about newspaper publication16 Nov 2021, 4:51PM Thyrocare Tech. - Quaterly Results13 Nov 2021, 7:28PM Thyrocare Technologies informs about disclosure17 Sep 2021, 10:22AM Thyrocare Technologies informs about disclosure6 Sep 2021, 9:50AM Thyrocare Technologies informs about disclosure3 Sep 2021, 10:09AM Thyrocare Technologies informs about book closure5 Jun 2021, 11:23AM Thyrocare Technologies informs about newspaper publication3 Jun 2021, 4:40PM Thyrocare Technologies informs about compliance report19 May 2021, 3:15PM Thyrocare Technologies informs about conference call6 Mar 2021, 3:25PM Thyrocare Technologies informs about disclosure20 Feb 2021, 2:44PM Thyrocare Technologies informs about Conference call4 Dec 2020, 3:25PM

Thyrocare Tech. Stock Price Analysis and Quick Research Report. Is Thyrocare Tech. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Thyrocare Tech. and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 105.68 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Thyrocare Tech. has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Thyrocare Tech. , the EPS growth was 26.8794942989445 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Thyrocare Tech. has OPM of 41.1073317543141 % which is a good sign for profitability.
     
  • ROE: Thyrocare Tech. have a healthy ROE of 31.6836841008543 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Thyrocare Tech.

X